Stop wasting resources on inferior precursors. For the serious longevity enthusiast, the data points to a clear winner.
The market for NAD+ boosters is a minefield of conflicting information, marketing hype, and questionable science. You're right to be sceptical. You have read the studies, followed the researchers, and now you face the "Hype vs. Reality" dilemma: which molecule actually works?
This article cuts through the noise. We will not use vague platitudes or promise miracles. Instead, we provide an evidence-led, rational breakdown for why NMNH (Reduced Nicotinamide Mononucleotide) is the only NAD+ precursor that should meet your exacting standards for purity, efficacy, and scientific integrity.
If you are a rational self-optimiser who demands measurable results, this is why NMNH warrants your full attention.